# FDA Inspection 1175112 - ANSTO Nuclear Medicine - June 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/ansto-nuclear-medicine/00d2e36a-5583-486b-8e51-fa22a04308d9
Source feed: FDA_Inspections

> FDA Inspection 1175112 for ANSTO Nuclear Medicine on June 24, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175112
- Company Name: ANSTO Nuclear Medicine
- Inspection Date: 2022-06-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 962746 - 2016-02-04](https://www.keypedia.com/records/fda_inspections/ansto-nuclear-medicine/153ac980-af9d-49c7-b6f1-03f66e054c5f)
- [FDA Inspection 612118 - 2009-08-14](https://www.keypedia.com/records/fda_inspections/ansto-nuclear-medicine/a9022031-7a6c-4cc8-95e1-a719cd09f54e)

Company: https://www.keypedia.com/companies/ansto-nuclear-medicine/9bb26b43-b1c1-4d57-9008-7563e01d67e2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c